Podcast Highlights

Treating the AD Patient During COVID-19

By Lindsay OConnorNovember 6, 2020April 1st, 2022No Comments

JDD Multimedia

JDD Podcast

Listen Now

How to Listen

Treating the AD Patient During COVID-19

Dr. Peter Lio and Dr. Adam Friedman

Atopic dermatitis is a relentless, recurring, unreasonable, often recalcitrant inflammatory skin disease that impacts millions of children and adults in the United States alone and requires a tailored treatment plan and ongoing follow up. Now add a global pandemic to the mix – awesome.

Join podcast host Dr Adam Friedman and atopic dermatitis antagonist Dr. Peter Lio as they discuss practical approaches to managing atopic dermatitis in the era of COVID-19. Telemedicine, topicals, and tons of systemic talk!

This podcast is supported by an independent medical education grant provided by Sanofi Genzyme & Regeneron Pharmaceuticals.

Learning Objectives:

Upon completion of this podcast, learners should be able to:

Formulate AD treatment plans that may decrease susceptibility and spread of viral infections, including COVID-19
Identify new and emerging therapeutic considerations for managing atopic dermatitis during the current COVID-19 pandemic

You May Also Like

Formulation Foundations: A Peak Behind the Development Curtain

Krista Reznik | Dermatology Podcast Archives, Featured Podcast, JDD Highlights, Podcast Highlights | No Comments

iTunes TuneIn Spotify Dr. David Osborne Finding the right formulation is not always a fun endeavor for the practitioner or patient, and can be the make or break for patient…

Reface the Chase: Paradigm shifts in the AD Management Strategy Mentality

Krista Reznik | Dermatology Podcast Archives, Featured Podcast, JDD Highlights, Podcast Highlights | No Comments

iTunes TuneIn Spotify Dr. Raj Chovatiya Who doesn't love a good game of "Whack a Mole?" Anyone? Just as you try to stay ahead of those furry, taunting, smiling devils…

Diving into Dyspigmentation: Discoloration Details and Future Directions

Krista Reznik | Dermatology Podcast Archives, Featured Podcast, JDD Highlights, Podcast Highlights | No Comments

iTunes TuneIn Spotify Dr. Andrew Alexis Dyspigmentation is defeating....for the patient and the practitioner as it is often a secondary feature of chronic inflammatory skin diseases and often a greater…

Get More from the JDD Podcast

Get the latest dermatology news delivered straight to your Inbox – sign up for the JDD Newsletter.

Discover the latest research, exclusive articles from leading dermatology experts,popular Podcast episodes, free CME activities, and more!

jddonline

Get ready for some updates! 🎉 Our Editor-in-Chi

Get ready for some updates! 🎉 Our Editor-in-Chief, Dr. Deborah S. Sarnoff, shares all the exciting updates to JDD in 2024! Don’t miss out—watch the full update here: https://ow.ly/b6U650Uaomx

JDD in the News: Hyperhidrosis & Sensitive Ski

JDD in the News: Hyperhidrosis & Sensitive Skin Connection; Dermatitis from Poppers

Read more at: https://jddonline.com/jdd-in-the-news-hyperhidrosis-dermatitis-from-poppers/

#dermatology #dermatologist #jddonline

"Enjoy these amazing Unlocked Access articles at h

"Enjoy these amazing Unlocked Access articles at https://ow.ly/QCh150U9OPj

#unlockedaccess #jdd #dermatology #dermatologist #dermjournal #medicaldermatology

All US healthcare providers who attend the full we

All US healthcare providers who attend the full webinar will receive a full size sample from the La Roche Posay product line.

Join Dr. Zoe Diana Draelos, MD and Dr. Hawasatu Dumbuya, PhD, for an informative and interactive webinar on managing symptoms of xerosis and atopic dermatitis in diverse ethnically patients with prebiotic skincare; new research on clinical manifestations & symptoms, plus impact on quality-of-life will be discussed.

https://tinyurl.com/bdh3pwax

📌 ON DEMAND Alert: Dr. Matthew Manish and Dr. K

📌 ON DEMAND Alert: Dr. Matthew Manish and Dr. Klint Peebles define basic terminology and concepts related to sex, gender, and sexual orientation. Learn about the unique clinical considerations needed when working with sexual and gender-diverse patients. Click the link to listen now!

https://ow.ly/xUSb50TXqY0

✍️ Test Your Dermatology Knowledge and Top the

✍️ Test Your Dermatology Knowledge and Top the Leaderboard: Take the MedChallenge Quiz!

Do you have the skills to identify skin conditions across all skin tones? Sponsored by Cetaphil and Galderma, sharpen your diagnostic eye with this five-question quiz featuring diverse skin types.

So, what’s the diagnosis…?

Click here to take the quiz and see how you rank: https://ow.ly/5g1r50TXk9O

📌 ON DEMAND Alert! Active ingredients are key

📌 ON DEMAND Alert! Active ingredients are key to the safety and power of cosmeceuticals. Join Dr. DiAnne Davis as she unveils insights on a new cosmeceutical formulation, covering its mechanisms and benefits. Don’t miss it! https://ow.ly/c7Tn50TVwTU

In an exclusive interview with JDD, Dr. Stein Gold

In an exclusive interview with JDD, Dr. Stein Gold delves deeper into the findings presented at RAD, offering valuable insights into how the “Level Up” study could influence treatment decisions moving forward.

Watch the full interview with Dr. Stein Gold as she shares her expert perspective on the “Level Up” study and what it means for patients and physicians alike: https://ow.ly/X7HF50TOCQb

#dermatology #VideoPearls #AtopicDermatitis

TONIGHT! All US healthcare providers who attend th

TONIGHT! All US healthcare providers who attend the full webinar will receive a full size product from La Roche Posay!

Register today: https://ow.ly/yChs50TAGX8

Dermatology Roundup: Semaglutide for HS, Acne Lase

Dermatology Roundup: Semaglutide for HS, Acne Laser Receives FDA Clearance

Read more at: https://ow.ly/FrIX50TNW8n

#dermatology #dermatologist #jddonline

Enjoy even more amazing Unlocked Access articles a

Enjoy even more amazing Unlocked Access articles at https://jddonline.com/issue/

#unlockedaccess #jdd #dermatology #dermatologist #dermjournal #medicaldermatology

Why Are Some IL-23 Biologics More Effective for Ps

Why Are Some IL-23 Biologics More Effective for Psoriasis?

Dive into the molecular mechanisms behind IL-23 biologics and discover what sets certain treatments apart in managing moderate to severe psoriasis. This new article from the Journal of Drugs in Dermatology breaks down key structural insights that could impact your clinical decisions. Stay ahead in the evolving world of biologics and optimize care for your patients.

Read the full article now: 🔗 https://jddonline.com/articles/structural-insights-what-makes-some-il-23-biologics-more-effective-in-psoriasis-S1545961624P0000X/

#Dermatology #Psoriasis #Biologics #IL23 #ClinicalDerm #JDD #MedicalResearch

Visit our Oats in Skincare Resource Center: https:

Visit our Oats in Skincare Resource Center: https://ow.ly/jeRI50TAHrk

Updated regularly with articles and research about the use of oats in the management of skin disorders and skin maintenance.

#oats #colloidal #colloidaloatmeal #resource #education #medical #doctor #dermtology #derm #dermatologist

Decoding Derm: What's the Diagnosis? Ready to tes

Decoding Derm: What's the Diagnosis?

Ready to test your dermatology knowledge? Dive into the first video in our series and see if you can identify the correct diagnosis!

Watch now: https://ow.ly/SVJ050TFips

#Dermatology #SkinHealth #JDD #DecodingDerm

🎙️ NEW PODCAST ALERT! Formulation Foundations

🎙️ NEW PODCAST ALERT! Formulation Foundations: A Peak Behind the Development Curtain with Guest Dr. David Osborne

Finding the right formulation is not always a fun endeavor for the practitioner or patient, and can be the make or break for patient adherence. In fact, an active ingredient without a thoughtful, purposeful, clinically translatable vehicle is like peanut butter without jelly ( though for us PB lovers who eat it from a spoon maybe that's not the best analogy). But how are we to think critically about the lotion or potion in which our cutting edge topical therapies are suspended/dissolved when this is not part of our training or CME? No need to answer because we've got the C.R.E.A.M. Joining podcast host Dr. Adam Friedman is formulation foreman Dr. David Osborne, Chief Technical Officer at Arcutis Therapeutics. Let's just say there is a really good chance you have prescribed something my man has invented over the past several decades. Uncap your knowledge gap and tune in to learn about key vehicle considerations to keep your form in check.

This podcast is funded by Arcutis Therapeutics

Listen now on your favorite podcast platform! 🎧 - https://ow.ly/VfKS50THUKw

#JDDPodcast #dermatology #dermatologist

Enjoy these amazing Unlocked Access articles at ht

Enjoy these amazing Unlocked Access articles at https://jddonline.com/issue/

#unlockedaccess #jdd #dermatology #dermatologist #dermjournal #medicaldermatology

Load More... Follow on Instagram

Tags:

Dr Adam Friedman Podcast

Leave a Reply

You must be logged in to post a comment.